CAS 871837-60-4

Pentanamide,N-[3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-2,3-dihydro-2-oxo-1H-indol-5-yl]-

Description:

Pentanamide, N-[3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-2,3-dihydro-2-oxo-1H-indol-5-yl]- is a complex organic compound characterized by its indole-based structure, which features multiple functional groups including an amide and a hydroxyimino group. This compound is likely to exhibit properties typical of indole derivatives, such as potential biological activity, including antimicrobial or anticancer effects, due to the presence of the indole moiety. The amide functional group suggests that it may have moderate solubility in polar solvents and could participate in hydrogen bonding, influencing its reactivity and interaction with biological targets. The presence of multiple rings and substituents indicates a potentially rigid structure, which may affect its conformational flexibility and, consequently, its biological activity. Additionally, the compound's molecular complexity may lead to unique pharmacokinetic properties, making it of interest in medicinal chemistry and drug development. Further studies would be necessary to elucidate its specific characteristics and potential applications.

Formula: C₂₁H₂₀N₄O₃

N-(3-(Hydroxyimino)-2'-oxo-[2,3'-biindolinylidene]-5'-yl)pentanamide

CAS: 871837-60-4

N-(3-(Hydroxyimino)-2'-oxo-[2,3'-biindolinylidene]-5'-yl)pentanamide

Purity: 98%

Molecular weight: 376.42g/mol

Ref: 54-OR1066372

DRAK2-IN-1

CAS: 871837-60-4

Drak2-in-1: ATP-competitive DRAK2 inhibitor; IC50 = 3 nM, KI = 0.26 nM; affects DRAK1 (IC50 = 51 nM).

Formula: C₂₁H₂₀N₄O₃

Color and Shape: Solid

Molecular weight: 376.41

Ref: TM-T11094